The scope of research being done at BRInj is diverse; one of the things that sets BRInj apart from other research institutes. Investigators from several disciplines and with unique skill sets are represented, and they work together under one roof to advance medical research in their respective fields, while simultaneously supporting investigators in other research areas.
Neurodegenerative diseases and other brain conditions affect a staggering number of Americans. Disorders of the central nervous system (CNS) are complex, and often difficult to understand and treat. Several researchers at BRInj are actively engaged in research to more clearly determine the factors that lead to the development of neurological conditions, and are using the latest information and technology to discover new therapies. Specific research areas include: Alzheimer’s disease (AD), stroke, Tourette Syndrome, depression, lysosomal storage disorders and dystonia. Read more >>
There has been dramatic progress in our understanding of neonatal physiology over the past 25 years, which has also been accompanied by the introduction of sophisticated technology to care for neonates. Taken together, these advances have led to a marked improvement in the survival rates of extremely premature infants. Nevertheless, complication rates are high for the most vulnerable patients and much remains to be done. Scientists and clinicians at BRInj are engaged in several projects to improve clinical outcomes for preterm and high-risk infants. Read more >>
Investigators at BRInj, in collaboration with Dr. John Halperin, operate a biobank with the one of the largest collections of serum and cerebrospinal fluid (CSF) samples from patients with nervous system Lyme disease and other neurological disorders. Using these priceless samples, studies are underway to more clearly understand the immune response in Lyme disease, and to identify new markers of nervous system infection.